Filing Details

Accession Number:
0001209191-21-057339
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-22 20:19:41
Reporting Period:
2021-09-20
Accepted Time:
2021-09-22 20:19:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1339970 Atyr Pharma Inc LIFE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236447 Paul Schimmel 3545 John Hopkins Court, Suite #250
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-20 250,000 $8.00 252,890 No 4 P Direct
Common Stock Disposition 2021-09-20 250,000 $0.00 2,890 No 5 G Direct
Common Stock Acquisiton 2021-09-20 250,000 $0.00 679,143 No 5 G Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 5 G Direct
No 5 G Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 113,023 Indirect See Footnote
Footnotes
  1. Represents shares purchased in an underwritten public offering at a public offering price of $8.00 per share.
  2. These shares are owned directly by Schimmel Revocable Trust U/A Dtd 9/6/2000. The Reporting Person and his spouse are trustees of the Schimmel Revocable Trust U/A Dtd 9/6/2000.
  3. These shares are owned directly by Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel. The Reporting Person is the sole owner of the Paul Schimmel Prototype PSP, Paul Schimmel Trustee, FBO Paul Schimmel.